{"id":"https://openalex.org/W206898877","doi":"https://doi.org/10.1182/blood.v122.21.1378.1378","title":"Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach","display_name":"Flow Cytometric Evaluation Of Minimal Residual Disease In Adult Acute Lymphoblastic Leukemia Using a Simplified, Single-Tube Approach","publication_year":2013,"publication_date":"2013-11-15","ids":{"openalex":"https://openalex.org/W206898877","doi":"https://doi.org/10.1182/blood.v122.21.1378.1378","mag":"206898877"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v122.21.1378.1378","doi":"https://doi.org/10.1182/blood.v122.21.1378.1378","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1378.1378","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053196203","display_name":"Roger Belizaire","orcid":"https://orcid.org/0000-0001-8496-287X","observed_orcids":["https://orcid.org/0000-0001-8496-287X"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roger Belizaire","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110632576","display_name":"Olga Pozdnyakova","orcid":"https://orcid.org/0000-0003-3529-5622","observed_orcids":["https://orcid.org/0000-0003-3529-5622"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Olga Pozdnyakova","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045421477","display_name":"Betty Li","orcid":"https://orcid.org/0009-0006-7293-9465","observed_orcids":["https://orcid.org/0009-0006-7293-9465"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Betty Li","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073166429","display_name":"Karry Charest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Karry Charest","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047939331","display_name":"Martha Wadleigh","orcid":"https://orcid.org/0000-0002-8191-1708","observed_orcids":["https://orcid.org/0000-0002-8191-1708"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Martha Wadleigh","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090527595","display_name":"David P. Steensma","orcid":"https://orcid.org/0000-0001-5130-9284","observed_orcids":["https://orcid.org/0000-0001-5130-9284"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Steensma","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039749707","display_name":"Gabriela Motyckova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gabriela Motyckova","raw_affiliation_strings":["Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027464923","display_name":"David M. Dorfman","orcid":"https://orcid.org/0000-0002-6244-8535","observed_orcids":["https://orcid.org/0000-0002-6244-8535"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David M. Dorfman","raw_affiliation_strings":["Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5045421477","https://openalex.org/A5047939331","https://openalex.org/A5053196203","https://openalex.org/A5073166429","https://openalex.org/A5110632576"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I4210117453"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.02823087,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":"21","first_page":"1378","last_page":"1378"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9660000205039978},{"id":"https://openalex.org/keywords/adult-acute-lymphoblastic-leukemia","display_name":"adult acute lymphoblastic leukemia","score":0.949999988079071},{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.8389999866485596},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":1.0},{"id":"https://openalex.org/keywords/bone-marrow-aspirate","display_name":"bone marrow aspirate","score":0.8309999704360962},{"id":"https://openalex.org/keywords/aberrant-immunophenotype","display_name":"aberrant immunophenotype","score":0.8809999823570251},{"id":"https://openalex.org/keywords/cd33","display_name":"CD33","score":0.7459999918937683},{"id":"https://openalex.org/keywords/relapse-detection","display_name":"relapse detection","score":0.5789999961853027},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.4269999861717224}],"concepts":[{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.8651026487350464},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.8557438254356384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6984837055206299},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5972766876220703},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.48186764121055603},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4520364999771118},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4239789843559265},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42299243807792664},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.4156111478805542},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4104557931423187},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.40863460302352905},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.36495283246040344},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3363400101661682},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13898169994354248},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.1147167980670929},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v122.21.1378.1378","doi":"https://doi.org/10.1182/blood.v122.21.1378.1378","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v122.21.1378.1378","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2166634848","https://openalex.org/W2204850921","https://openalex.org/W2364165287","https://openalex.org/W7096643615","https://openalex.org/W2106176441","https://openalex.org/W2008495298","https://openalex.org/W4403416959","https://openalex.org/W2613416346","https://openalex.org/W4413786902","https://openalex.org/W4413791098"],"abstract_inverted_index":{"Abstract":[0],"Flow":[1,33],"cytometry":[2,34,85,103,159,281,365,400,422,447,560],"for":[3,35,86,155,174,277,387,521],"detection":[4,88],"of":[5,31,42,65,83,144,185,196,213,227,238,252,258,309,319,369,391,404,408,429,476,483,496,502,516,598,603,615,624,629,646],"minimal":[6],"residual":[7],"disease":[8,218,320,370],"(MRD)":[9],"in":[10,19,59,89,108,235,371,413,435,453,469,539,569,596],"acute":[11],"lymphoblastic":[12],"leukemia":[13,137],"(ALL)":[14],"has":[15,93],"been":[16,94],"widely":[17],"used":[18,565,620],"pediatric":[20],"patients":[21,92,120,123,128,134,187,215,260,415,437,452,485,504,540],"to":[22,27,77,105,566,584,621,648],"quantify":[23],"therapeutic":[24],"response":[25],"and":[26,52,132,139,165,233,321,348,442,499,532,545,609,637],"assess":[28],"the":[29,39,78,81,179,206,236,250,293,332,372,378,388,392,427,450,549,601,630],"risk":[30],"relapse.":[32],"MRD":[36,57,87,107,156,170,278,420,445,568,604,616,633],"provides":[37],"roughly":[38],"same":[40],"level":[41],"sensitivity":[43],"(0.01%)":[44],"as":[45,284,297,336,396],"molecular":[46],"methods":[47],"but":[48,376],"at":[49,473,572],"lower":[50],"cost":[51,575],"with":[53,124,129,135,142,191,219,416,426,438,487,506,541,576,586,607],"faster":[54],"turnaround":[55,578],"time.":[56],"assessment":[58,79,617],"ALL":[60,91,116,571],"currently":[61],"requires":[62],"an":[63,192,263,507],"evaluation":[64],"20":[66],"or":[67,149,162,203,289,306,465,479,589],"more":[68],"parameters":[69],"divided":[70],"among":[71],"multiple":[72],"tubes.":[73],"In":[74,529,552],"part":[75],"due":[76],"complexity,":[80],"use":[82],"flow":[84,102,158,280,339,364,399,421,446,559],"adult":[90,115,570,625],"relatively":[95,573],"limited.":[96],"We":[97,432],"developed":[98],"a":[99,197,220,327,354,492,512,556,593],"6-color,":[100],"single-tube,":[101,558],"assay":[104,561],"detect":[106,567],"bone":[109],"marrow":[110],"(BM)":[111],"aspirate":[112,305,382],"specimens":[113,275],"from":[114,245],"patients.":[117],"The":[118,168,210],"73":[119,451],"included":[121],"52":[122],"B-ALL":[125,186,214,414],"(71%),":[126],"19":[127],"T-ALL":[130,259],"(26%)":[131],"2":[133],"T/myeloid":[136],"(3%)":[138],"were":[140,153,243,282,343,412,461,472,537],"treated":[141],"one":[143],"several":[145],"standard":[146],"chemotherapeutic":[147],"regimens":[148],"targeted":[150],"therapies.":[151],"Patients":[152,468],"tested":[154],"by":[157,269,279,338,346,363,398,548],"after":[160],"induction":[161],"re-induction":[163],"therapy":[164],"serially":[166],"thereafter.":[167],"6-marker":[169],"panel":[171],"was":[172,205,361,385,582,605],"customized":[173],"each":[175],"patient":[176,638],"based":[177,248],"on":[178,249],"18-20-marker":[180],"diagnostic":[181],"immunophenotype.":[182],"Sixty-three":[183],"percent":[184,257],"(n=33)":[188],"had":[189,217,262,366,401,457],"lymphoblasts":[190],"aberrant":[193,264,590],"immunophenotype;":[194],"expression":[195,226],"myeloid":[198],"marker":[199,254],"(e.g.,":[200],"CD13,":[201],"CD15":[202],"CD33)":[204],"most":[207,266],"common":[208],"aberrancy.":[209],"remaining":[211],"37%":[212],"(n=19)":[216],"hematogone":[221,417,588],"immunophenotype,":[222,265,591],"which":[223],"comprised":[224],"surface":[225,253],"CD10,":[228],"CD19,":[229],"CD20,":[230],"CD34,":[231],"CD38":[232],"CD45;":[234],"majority":[237],"these":[239],"cases,":[240],"leukemic":[241],"cells":[242],"distinguishable":[244],"normal":[246],"hematogones":[247],"intensity":[251],"expression.":[255,271],"Forty-seven":[256],"(n=9)":[261],"often":[267],"characterized":[268],"CD33":[270],"One-hundred":[272],"forty-six":[273],"consecutive":[274],"analyzed":[276],"classified":[283,296,335,395],"positive":[285,444],"(23%),":[286],"negative":[287,337,345,362,439],"(72%)":[288],"uncertain":[290,397,410],"(5%).":[291],"Of":[292,331,449],"34":[294],"samples":[295,313,334,394],"positive,":[298],"14":[299],"(41%)":[300],"showed":[301,423],"morphologic":[302,317,329,356,367,402,430,440],"(i.e.,":[303],"BM":[304],"biopsy)":[307],"evidence":[308,318,368,403],"disease;":[310,405],"nineteen":[311],"(65%)":[312],"did":[314,324,351],"not":[315,325,352,377],"show":[316],"1":[322,349],"sample":[323,350,359],"have":[326,353],"concurrent":[328,355],"assessment.":[330,357,431],"105":[333],"cytometry,":[340],"103":[341],"(98%)":[342],"also":[344],"morphology":[347],"One":[358],"that":[360,381,460,562,612],"biopsy":[373],"(10-20%":[374],"blasts)":[375],"aspirate,":[379],"suggesting":[380,611],"sampling":[383],"artifact":[384],"responsible":[386],"discrepancy.":[389],"None":[390],"7":[393,409],"five":[406],"out":[407,482,501],"classifications":[411],"immunophenotypes.":[418],"Overall,":[419],"86%":[424],"concordance":[425],"results":[428,441,459,489,543],"evaluated":[433],"outcomes":[434,639],"all":[436],"any":[443],"result(s).":[448],"this":[454,470],"study,":[455],"61":[456],"morphology-negative":[458],"either":[462,587],"MRD-negative":[463,488],"(n=45)":[464],"MRD-positive":[466,508,542],"(n=16).":[467],"group":[471],"various":[474],"points":[475],"treatment":[477,623],"post-induction":[478],"re-induction.":[480],"Four":[481],"45":[484],"(9%)":[486],"relapsed":[490,510],"during":[491,511],"median":[493,513],"follow-up":[494,514],"period":[495,515],"22":[497],"months,":[498],"8":[500],"16":[503],"(50%)":[505],"result":[509,595],"15":[517],"months":[518],"(odds":[519],"ratio":[520],"relapse":[522,608],"10.3,":[523],"95%":[524,597],"confidence":[525],"interval":[526],"2.5-42.4,":[527],"P=0.001).":[528],"addition,":[530],"relapse-related":[531],"overall":[533],"mortality":[534],"(Figure":[535],"1)":[536],"higher":[538],"(P=0.0023":[544],"P=0.0016,":[546],"respectively,":[547],"log-rank":[550],"test).":[551],"summary,":[553],"we":[554],"present":[555],"simplified,":[557],"can":[563],"be":[564,619],"low":[574],"rapid":[577],"time;":[579],"our":[580,613],"approach":[581],"applicable":[583],"cases":[585],"yielding":[592],"definitive":[594],"cases.":[599],"Notably,":[600],"presence":[602],"associated":[606],"mortality,":[610],"method":[614],"could":[618],"guide":[622],"ALL.":[626],"Further":[627],"analysis":[628],"correlations":[631],"between":[632],"results,":[634],"clinical":[635],"management":[636],"is":[640],"ongoing.":[641],"Disclosures:":[642],"No":[643],"relevant":[644],"conflicts":[645],"interest":[647],"declare.":[649]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}